Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

JAM3 Antikörper

JAM3 Reaktivität: Human, Maus FACS, IHC (fro), IF Wirt: Ratte Monoclonal CRAM-18 F26 unconjugated
Produktnummer ABIN2475176
  • Target Alle JAM3 Antikörper anzeigen
    JAM3 (Junctional Adhesion Molecule 3 (JAM3))
    Reaktivität
    • 56
    • 45
    • 30
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    Human, Maus
    Wirt
    • 42
    • 14
    • 4
    • 1
    Ratte
    Klonalität
    • 43
    • 18
    Monoklonal
    Konjugat
    • 29
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser JAM3 Antikörper ist unkonjugiert
    Applikation
    • 36
    • 14
    • 14
    • 13
    • 13
    • 13
    • 12
    • 11
    • 7
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Produktmerkmale
    Purified IgG
    Aufreinigung
    Purified
    Immunogen
    Recombinant soluble JAM-C
    Klon
    CRAM-18 F26
    Isotyp
    IgG2a
    Top Product
    Discover our top product JAM3 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0 mg/mL
    Konservierungsmittel
    Without preservative
  • Johnson-Léger, Aurrand-Lions, Beltraminelli, Fasel, Imhof: "Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration." in: Blood, Vol. 100, Issue 7, pp. 2479-86, (2002) (PubMed).

    Aurrand-Lions, Duncan, Ballestrem, Imhof: "JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2733-41, (2001) (PubMed).

    Aurrand-Lions, Johnson-Leger, Wong, Du Pasquier, Imhof: "Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members." in: Blood, Vol. 98, Issue 13, pp. 3699-707, (2001) (PubMed).

  • Target
    JAM3 (Junctional Adhesion Molecule 3 (JAM3))
    Andere Bezeichnung
    JAM-C (JAM3 Produkte)
    Synonyme
    JAM3 antikoerper, jam3 antikoerper, sr:nyz155 antikoerper, wu:fb30h11 antikoerper, wu:fc08c06 antikoerper, wu:fc13e04 antikoerper, wu:fc25g11 antikoerper, jamc.2 antikoerper, 1110002N23Rik antikoerper, JAM-3 antikoerper, JAM-C antikoerper, Jcam3 antikoerper, JAM-2 antikoerper, JAMC antikoerper, junctional adhesion molecule 3 antikoerper, junctional adhesion molecule 3b antikoerper, junctional adhesion molecule 3a antikoerper, junction adhesion molecule 3 antikoerper, JAM3 antikoerper, jam3b antikoerper, jam3a antikoerper, Jam3 antikoerper
    Hintergrund
    Synonyms: JAM-3
    Gen-ID
    83700, 83964
    UniProt
    Q9BX67, Q9D8B7
Sie sind hier:
Kundenservice